Compare COYA & RFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COYA | RFAM |
|---|---|---|
| Founded | 2020 | 2025 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.6M | 138.5M |
| IPO Year | 2022 | 2026 |
| Metric | COYA | RFAM |
|---|---|---|
| Price | $4.39 | $9.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $15.80 | N/A |
| AVG Volume (30 Days) | ★ 150.3K | 11.0K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,945,753.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $763.10 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 123.57 | N/A |
| 52 Week Low | $3.71 | $9.77 |
| 52 Week High | $7.75 | $9.94 |
| Indicator | COYA | RFAM |
|---|---|---|
| Relative Strength Index (RSI) | 49.68 | 49.89 |
| Support Level | $3.83 | $9.79 |
| Resistance Level | $5.14 | $9.94 |
| Average True Range (ATR) | 0.31 | 0.02 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 37.96 | 44.12 |
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
RF Acquisition Corp III is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.